Customvis Share Discussion Threads

[induna123] 10/11/2009 16:17

Just wait for the directors to start buying. They know this is company changing news. Sell a few more laser units and we should be heading for 2p+

[pre] 10/11/2009 15:39

..looks like we have a buyer folks...someone hoovering up shares....interesting.

[pre] 10/11/2009 15:29

...indicators on blue....tick up coming?

[induna123] 10/11/2009 14:22

Is that 1.4 trade a buy or sell. Confusing with this spread.

[pre] 10/11/2009 11:43

greedy mm's have a cunning plan here....accumulating stock and moving share price up....

[pre] 10/11/2009 11:42

...slowly but surely moving up...good to see a quiet thread.....plenty of upside here....broker note to come....we should be getting more newsflow too as deals will be done....excellent....

[induna123] 06/11/2009 13:22

OK. We have two new threads now, take your pick ;)

[alcatraz10] 06/11/2009 13:21

Presbyopia Approval (Customvis)





TIDMCUS

RNS Number : 1047C
CustomVis plc
06 November 2009


Presbyopia Approval


CustomVis (AIM: CUS), the leading developer, manufacturer and distributor of
solid state laser systems for the refractive surgical industry is pleased to
announce it has been granted approval for its presbyopia treatment by the
Therapeutic Goods Administration ("TGA"), Australia's regulatory agency for
medical drugs and devices.


The approval is a major achievement for the Group, becoming one of the first
refractive laser developers in the world to be granted regulatory approval for
the treatment of presbyopia. As well as Australian approval, the treatment has
been granted European CE approval, allowing the procedure to be carried out
within the European Union. The Directors believe this is the first presbyopia
treatment of this method of laser surgery to receive CE approval.


Presbyopia is an age-associated progressive loss of the focusing power of the
eye's lens, making it difficult to see objects close-up. Most people over the
age of 40 will suffer from it to some degree and current treatment options are
limited, generally meaning the use of reading glasses, bifocal glasses or the
invasive insertion of intraocular lenses, none of which offer a true solution.


CustomVis, over the past few years, has pioneered a technique which will restore
close-up vision while the patient retains good long distance sight.


The Group's installed base of Pulzar Z1 lasers will be capable of conducting the
PresBvis(TM) presbyopia treatment through this regulatory approval. The Group
expects to conduct simple software upgrades over the next two months, thereby
allowing surgeons operating the Pulzar Z1 lasers to begin offering this
treatment to their patients shortly.


PresBvis(TM) users will be charged on a per-patient basis, bringing a new cash
flow stream into the business, with fees paid in advance to CustomVis for each
treatment performed.


Dr. Paul van Saarloos, Chief Executive of CustomVis, commented, "Being one of
the first laser developers in the world to offer this highly specialised
treatment for a very common problem will give us a big competitive advantage. As
well as being a new and additional source of revenue for the Group we anticipate
it will lead to expanded sales of the Pulzar Z1."

[induna123] 06/11/2009 13:12

Can somebody start a new thread with the charts in it + a new header, something more relevant with today's news?

[induna123] 06/11/2009 12:36

Wow, this is big news. I know about laser eye surgery. So far they've only been able to correct myopia (short sighted vision) but this is much bigger as if effects a huge percentage of people over 40. This could be massive for CUS.

I'm in!

[alcatraz10] 06/11/2009 11:59

Neddo

i think the NHS patients is quite a big market, plus it has CE and now Australian approval.

[neddo] 06/11/2009 11:57

does'nt it have a ltd market, after all, it's not being sold to the general public?